Last reviewed · How we verify

NCT06230250: RMSU-LDPEM

Unilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap After Breast Cancer

Status unknown Last updated 28 February 2024
What this trial tests

trial in Patient Satisfaction in 22 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
28 February 2024
28 February 2024

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment22
Start date1 October 2023
Primary completion28 February 2024
Estimated completion28 February 2024
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

Eligibility, female only, with Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of pedicled dorsal flaps sparing the latissimus dorsi muscle (TDAP and MSLD flap) is a well-described reconstruction method in breast reconstruction after breast cancer. However, little data exists regarding patient satisfaction after this surgery. The main objective of this study was to evaluate patient satisfaction after unilateral total secondary breast reconstruction using a TDAP or MSLD flap.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Patient Satisfaction

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06230250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing